e-learning
resources
ERS Research Seminars
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Benefit versus risk of innovation for industry
R. Strieter (Cambridge, United States of America)
Source:
Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
Number:
11
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Strieter (Cambridge, United States of America). Benefit versus risk of innovation for industry. Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Perception and awareness about tobacco industry among policy makers
Source: Annual Congress 2013 –E-cigarettes, shisha, the tobacco industry and public health
Year: 2013
The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level
Source: Eur Respir J 2008; 31: 924-926
Year: 2008
The value proposition of medical technology: an industry perspective
Source: Research Seminar 2015 - Personalising respiratory care in Europe
Year: 2015
Is electronic-cigarette a tobacco industry discovery?
Source: International Congress 2015 – E-cigarette, sisha and waterpipe
Year: 2015
Asthma research in Europe: a transformative agenda for innovation and competitiveness
Source: Eur Respir J, 49 (5) 1602294; 10.1183/13993003.02294-2016
Year: 2017
Controlling passive smoking through legislation in Ireland: an attack on civil liberty or good public health policy?
Source: Eur Respir J 2004; 24: 337-338
Year: 2004
Predictive value of annual costs on 3-year mortality in COPD
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015
Interoperability in healthcare: benefits and challenges
Source: International Congress 2016 – Implementation of collaborative lung function testing
Year: 2016
Using mortality reviews to shape future service planning
Source: Annual Congress 2013 –World tour of tobacco epidemiology
Year: 2013
Investment and export incentives granted to tobacco industry in Turkey
Source: International Congress 2017 – Global epidemiologic data on smoking
Year: 2017
The successful efforts of the industry to influence smoking legislation in Switzerland since 1990 up to now: lessons from the analysis of the parliamentary process on cantonal and federal level
Source: Annual Congress 2009 - Tobacco: from smoke to disease
Year: 2009
Digital health technology for the end TB strategy: Developing priority products and making them work
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016
European reference networks: moving towards a tangible outcome of the European Union's cross-border healthcare directive?
Source: Eur Respir J 2016; 48: 1564-1568
Year: 2016
New threats from the tobacco industry (IQOS and electronic cigarettes): the role of medical scientific societies
Source: International Congress 2019 – The future of respiratory diseases: what prevention can do
Year: 2019
Implementation of smokefree policies in healthcare institutions: Package approach
Source: International Congress 2016 – Public health related concerns and epidemiology of smoking and smoking-related products
Year: 2016
Implementing local guidelines: the potential for cost savings and improvement of patient care
Source: Eur Respir J 2006; 28: Suppl. 50, 319s
Year: 2006
Comparative study about perception of tobacco package disease risk warning and aware COPD among intergenerational/institutional
Source: International Congress 2015 – Epidemiology, public health and economics of tobacco
Year: 2015
Title: The effect of COPD pay-for-performance program on healthcare resource utilization in Taiwan
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept